• Home |
• Downloads |
• Glossary |
• Sitemap

Financial Statements

• Preparation of the Financial Statements and Directors' Responsibilities
• Directors' Responsibilities for, and Report on, Internal Control over Financial Reporting
• Auditors' Reports on the Financial Statements and on Internal Control over Financial Reporting (Sarbanes-Oxley Act Section 404)
• Independent Auditors' Report to the Members of AstraZeneca PLC (Group)
• Consolidated Income Statement
• Consolidated Statement of Recognised Income and Expense
• Consolidated Balance Sheet
• Consolidated Cash Flow Statement
• Accounting Policies (Group)
• Notes to the Financial Statements (Group)
• Principal Subsidiaries
• Independent Auditors' Report to the Members of AstraZeneca PLC (Company)
• Company Balance Sheet
• Accounting Policies (Company)
• Notes to the Financial Statements (Company)
• Group financial record

Auditors' Reports on the Financial Statements and on Internal Control over Financial Reporting (Sarbanes-Oxley Act Section 404)

The report set out below is provided in compliance with International Standards on Auditing (UK and Ireland). KPMG Audit Plc has also issued reports in accordance with auditing standards of the Public Company Accounting Oversight Board in the US, which will be included in the Annual Report on Form 20-F to be filed with the US Securities and Exchange Commission. Those reports are unqualified and include opinions on the financial statements and on the effectiveness of internal control over financial reporting as at 31 December 2007 (Sarbanes-Oxley Act Section 404). The Directors’ statement on internal control over financial reporting is set out in the Directors' Responsibilities for, and Report on, Internal Control over Financial Reporting.

KPMG Audit Plc has also reported separately on the Company Financial Statements of AstraZeneca PLC and on the information in the Directors’ Remuneration Report that is described as having been audited.